Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Implant or insert
Reexamination Certificate
2005-02-01
2005-02-01
Azpuru, Carlos A. (Department: 1615)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Implant or insert
C424S430000, C424S434000, C424S435000, C424S443000, C424S045000
Reexamination Certificate
active
06849267
ABSTRACT:
This invention provides a method of treating a disease state in mammals that is alleviated by treatment with a protein kinase inhibitor, especially an ERK inhibitor, which method comprises administering a compound having the pharmacophoric features Grp1, Grp2 and Grp3:Grp 1 is an optionally substituted aryl or aliphatic group; Grp 2 is a heteroaromatic ring having one to three nitrogens, said ring comprising a hydrogen bond acceptor HBA2 optionally bonded to a hydrogen bond donor HBD2, and Grp3 is a heteroaromatic ring comprising a hydrogen bond donor HBD1, with distances between the pharmacophoric features defined in the specification. The method is useful for treating cancer, stroke, diabetes, hepatomegaly, cardiovascular disease, Alzheimer's disease, cystic fibrosis, viral disease, autoimmune diseases, atherosclerosis, restenosis, psoriasis, allergic reactions, inflammation, neurological disorders or a hormone-related disease.
REFERENCES:
patent: WO9910325 (1999-03-01), None
Bemis Guy
Xie Xiaoling
Andrea Robidoux Vertex Pharmaceuticals Incorporated
Azpuru Carlos A.
Vertex Pharmaceuticals Incorporated
LandOfFree
Compositions useful as inhibitors of ERK does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions useful as inhibitors of ERK, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions useful as inhibitors of ERK will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3446466